TELO
Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ: TELO · HEALTHCARE · BIOTECHNOLOGY
$1.40
-3.45% today
Updated 2026-04-30
Market cap
$99.72M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.33
Dividend yield
—
52W range
$1 – $3
Volume
0.1M
Telomir Pharmaceuticals, Inc. Common Stock (TELO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-119396.00 | $-468661.00 | $-3.86M | $-5.07M | $-3.69M |
| Capital expenditures | $4.00 | $0.00 | $4.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | — | — | $0.00 | $6.87M | $5.29M |
| Free cash flow | $-119400.00 | $-468661.00 | $-3.86M | $-5.07M | $-3.69M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |